John Tozzi is a Reporter at Bloomberg News. He covers a range of topics including health care, finance, and business, with a focus on evidence-based reporting. John’s work has been featured in prominent publications such as Bloomberg-Quint, Fortune, and The Japan Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
John Tozzi's coverage predominantly focuses on the healthcare and pharmaceutical industries, delving into topics such as hospital pricing, mergers and acquisitions, health insurance, and employee power. He provides informed insights through a variety of sources including data citations, press releases, government announcements, and legal policy regulations.
To effectively engage with John Tozzi consider providing expert commentary or insights based on reliable data to support your pitch. Topics related to hospital pricing transparency, industry mergers & acquisitions or regulatory changes in the healthcare sector would be relevant for his coverage. If you have expertise in these areas or access to pertinent data or information that could shed light on these issues it may be valuable to reach out.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ike Swetlitz, John Tozzi, Leah Nylen
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average acquisition cost for dozens of specialty generic drugs, bringing in more than $7.3 billion in excess revenue over six years, the Federal Trade Commission said in a report on the drug middlemen.
By: Leah Nylen, John Tozzi, Ike Swetlitz
By Leah Nylen, John Tozzi, Ike Swetlitz | Bloomberg News Units of CVS Health Corp., Cigna Group and UnitedHealth Group charged significantly
Hi, it’s John in New York. While Wall Street is still trying to figure out how widespread use of weight-loss drugs will affect the economy, another drug is shaping shopping behavior. More on that shortly, but first ...
UnitedHealth Group Inc. is set to report financial results Thursday, the first time its executives will speak publicly since the insurance unit’s chief Brian Thompson was killed last month.
UnitedHealth Group Inc. is set to report financial results Thursday, the first time its executives will speak publicly since the insurance unit's chief Brian Thompson was killed last month.
UnitedHealth Group Inc. reported fourth-quarter profit that surpassed Wall Street’s expectations in its first financial statement since a top executive was killed in New York last month.
(Bloomberg) -- UnitedHealth Group Inc. reported higher medical costs for the year than Wall Street expected in its first financial statement since a top executive was killed in New York last month.
In This Article UNH (Bloomberg) -- UnitedHealth Group Inc. shares fell after elevated medical costs persisted in the fourth quarter and revenue missed estimates.
Medical companies face rising scrutiny for tracking technology Health plan says user data went to Google, Microsoft, X
UnitedHealth Group Inc. promoted the head of its Medicare health plan business to lead the company’s broader insurance division, filling the job previously held by slain executive Brian Thompson.
(833) 317-6278 
